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Abstract
Background: Clinical decision support (CDS), including computerized reminders for providers and patients, can improve health
outcomes. CDS promoting influenza vaccination, delivered directly to patients via an electronic health record (EHR) patient
portal and interactive voice recognition (IVR) calls, offers an innovative approach to improving patient care.
Objective: To test the effectiveness of an EHR patient portal and IVR outreach to improve rates of influenza vaccination in a
large multispecialty group practice in central Massachusetts.
Methods: We describe a nonblinded, randomized controlled trial of EHR patient portal messages and IVR calls designed to
promote influenza vaccination. In our preparatory phase, we conducted qualitative interviews with patients, providers, and staff
to inform development of EHR portal messages with embedded questionnaires and IVR call scripts. We also provided practice-wide
education on influenza vaccines to all physicians and staff members, including information on existing vaccine-specific EHR
CDS. Outreach will target adult patients who remain unvaccinated for more than 2 months after the start of the influenza season.
Using computer-generated randomization and a factorial design, we will assign 20,000 patients who are active users of electronic
patient portals to one of the 4 study arms: (1) receipt of a portal message promoting influenza vaccines and offering online
appointment scheduling; (2) receipt of an IVR call with similar content but without appointment facilitation; (3) both (1) and (2);
or (4) neither (1) nor (2) (usual care). We will randomize patients without electronic portals (10,000 patients) to (1) receipt of
IVR call or (2) usual care. Both portal messages and IVR calls promote influenza vaccine completion. Our primary outcome is
percentage of eligible patients with influenza vaccines administered at our group practice during the 2014-15 influenza season.
Both outreach methods also solicit patient self-report on influenza vaccinations completed outside the clinic or on barriers to
influenza vaccination. Self-reported data from both outreach modes will be uploaded into the EHR to increase accuracy of existing
provider-directed EHR CDS (vaccine alerts).
JMIR Res Protoc 2016 | vol. 5 | iss. 2 | e56 | p.1http://www.researchprotocols.org/2016/2/e56/
(page number not for citation purposes)
Cutrona et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
Results: With our proposed sample size and using a factorial design, power calculations using baseline vaccination rate estimates
indicated that 4286 participants per arm would give 80% power to detect a 3% improvement in influenza vaccination rates between
groups (α=.05; 2-sided). Intention-to-treat unadjusted chi-square analyses will be performed to assess the impact of portal messages,
either alone or in combination with the IVR call, on influenza vaccination rates. The project was funded in January 2014. Patient
enrollment for the project described here completed in December 2014. Data analysis is currently under way and first results are
expected to be submitted for publication in 2016.
Conclusions: If successful, this study’s intervention may be adapted by other large health care organizations to increase
vaccination rates among their eligible patients.
ClinicalTrial: ClinicalTrials.gov NCT02266277; https://clinicaltrials.gov/ct2/show/NCT02266277 (Archived by WebCite at
http://www.webcitation.org/6fbLviHLH).
(JMIR Res Protoc 2016;5(2):e56)   doi:10.2196/resprot.5478
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Introduction
Clinical decision support (CDS), including computerized
reminders for providers and patients, can improve health
outcomes by supporting the delivery of evidence-based and
guideline-concordant medical care [1,2]. Many health systems
effectively use provider-directed CDS. These provider-directed
prompts frequently take the form of noninterruptive or
interruptive “pop-up” alerts, reminding providers of
recommended prevention or screening measures. While effective
in many situations, provider-directed CDS is subject to important
limitations. Instructions contained in alerts are often ignored or
overridden due to alert fatigue [3-6]. Providers may also start
to mistrust alerts if these are frequently triggered by erroneous
or incomplete electronic health record (EHR) data. In light of
these challenges, and in the setting of nationwide adoption of
electronic patient portals, patient-directed CDS delivered via
portal offers an innovative approach to improving patient care.
Electronic patient portals are secure websites that provide
patients with 24-hour online access to limited EHR information.
A portal provides patients with a personal health record
“tethered” to their EHR [7]. Accessible information within a
tethered portal varies by health system but may include
vaccinations, laboratory results, and information from recent
doctor visits or hospitalizations. Patients also use portals in
numerous interactive ways including requesting prescription
refills, scheduling nonurgent appointments, and seeking
educational materials; portals can also provide a valuable link
to Internet-based local and public health resources [8,9]. A core
function of portals is secure messaging—electronic
communication with the physician or health care team. A recent
review found portals to have facilitated improved
patient-provider communication with 10 of 27 articles reporting
a positive association with portal’s secure messaging [10,11].
Advantages of tethered portals include enhancement of
patient-provider communication, patient empowerment, support
for care between visits, and improved patient outcomes [10].
Patient portals have been shown to improve medication
adherence, decrease office visits, increase self-management of
disease and disease awareness, increase use of preventative
medicine, and increase inclusion of patients in medical decision
making [12,13]. While studies of portal use show promising
results, to date few randomized trials have tested the impact of
patient-directed CDS via portal on receiving
guideline-concordant care.
Vaccinations are a preventive measure well suited for
incorporation into a patient-directed CDS intervention via patient
portals. Previous patient outreach interventions have been shown
to improve rates of vaccine completion and have been tested
using multiple options including mailed letters, post cards,
person-to-person phone calls, automated phone messages, and
post card and phone combination [14,15]. Few studies have
tested the use of patient-directed vaccine reminders sent via
patient portals; those that have done so have focused exclusively
on untethered (ie, personally controlled) patient health records
[16]. Influenza vaccines are a logical target for patient-directed
CDS because they are familiar to the general population and
are recommended widely but completed at suboptimal rates.
Influenza infections contribute to increased health care costs
and loss of productivity, and can lead to serious medical
complications and even death [17]. The effect is felt most in
high-risk groups such as adults aged 65 years or older and those
diagnosed with cancer or diabetes [18]; however, low-risk
groups also suffer the consequences. In 2007, it was estimated
that influenza infections were responsible for 31.4 million
outpatient visits, with reports indicating direct medical expenses
amounting up to US $10.4 billion (including inpatient, outpatient
and pharmaceutical claims) and lost earnings due to death and
illness costing about US $16.3 billion [19,20]. According to
CDC estimates, during the 2013-14 influenza season, influenza
vaccination resulted in approximately 7.2 million fewer illnesses
and 90,068 fewer hospitalizations. Despite numerous reasons
to protect against influenza, only 45% of the US population
received influenza vaccinations during the 2012-13 influenza
season [21].
Our intervention, which will be implemented in a large
multispecialty group practice in central Massachusetts, aims to
improve rates of influenza vaccination among eligible adult
patients by using a patient-directed CDS. We also aim to
improve the accuracy of existing provider-directed CDS
(influenza vaccine alerts) by capturing information on vaccines
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completed outside the clinic and using this self-reported patient
information to update EHRs. We herein describe the protocol
for a randomized controlled trial using EHR patient portal
messages and interactive voice recognition (IVR) calls to (1)
deliver messages promoting influenza vaccine completion and
(2) solicit patient self-report on vaccines completed outside the
clinic and on barriers to vaccination.
Methods
Study Objectives
Our overarching goal is to improve rates of influenza vaccination
among eligible adults at Reliant Medical Group (RMG). We
are conducting this randomized outreach intervention with the
following main objectives that support this goal: (1) to determine
whether our outreach increases likelihood of influenza
vaccination (and if so, whether one mode of outreach is most
effective); (2) to improve documentation of influenza
vaccinations administered outside the practice by inviting patient
self-report (improving accuracy of existing decision support
tools); and (3) to deliver to patients targeted factual vaccine
information related to that patient’s concerns.
Study Outcomes
The primary study outcome is the percentage of eligible patients
receiving influenza vaccines administered at our group practice
during the 2014-15 influenza season. We will also study process
measures including percentage of message recipients reached
(ie, percentage of those who answer the IVR call and percentage
of those who open the portal message) and number of
intervention patients who self-report influenza vaccines
administered in the community.
Study Design
We will conduct a nonblinded, randomized controlled trial
directed at patients who, by November 2014, do not have
influenza vaccinations for the 2014-15 influenza season recorded
in the EHR. Among these patients, those also overdue for
pneumococcal vaccination(s) will receive outreach messages
with additional language encouraging them to speak with their
health care provider as well as a link to access more information
about pneumococcal vaccination. Description of the
pneumococcal vaccine intervention and analysis will not be a
focus of this paper.
Authors designed and will implement the study, and will have
full oversight and responsibility for data collection, analysis,
and manuscript preparation.
Theoretical Model
The Communication Human Information Processing model
[22,23] (Figure 1) provides the overarching framework for the
design and implementation of the intervention components.
Growing out of extensive research on effective communication
of safety information, this model includes the core concepts of
communication theory (ie, message source, channel, and
receiver) while highlighting the need to enhance effective
information processing. Effective information processing
requires attention to and comprehension of the message (eg,
that a vaccine is needed); these processes are influenced by
attitudes and beliefs, and motivation. In the context of
vaccination, beliefs about susceptibility, severity, disease
likelihood, and vaccine effectiveness are likely to be important
[24]. All of these processes in turn influence behavior (ie,
vaccination). Our interventions are designed to garner attention,
be easily understood, address critical beliefs, and motivate
vaccination.
Study Procedures
This study consists of two phases, namely, (1) preintervention
study components and (2) IVR and portal randomized outreach
intervention.
Phase 1: Preintervention
To develop provider, staff, and patient outreach content, we
conducted 30 in-depth interviews with patients, providers, and
staff. Patient interviews elicited reasons for getting vaccinated,
barriers to vaccination, and feedback to inform development of
patient outreach materials used for the intervention. Provider
and staff perceptions of patient barriers to vaccination helped
to further shape patient outreach materials.
Information from interviews also informed our educational
outreach; 10-minute in-person presentations were given by
physician researchers who were also well-respected members
of the group practice. Presentations were incorporated into
routine clinical practice meetings attended by both physicians
and staff. Based on results from provider and staff interviews,
the in-person presentation provided an overview of this study
and also provided information on pneumococcal vaccine
guidelines. Follow-up emails sent bimonthly to all physicians
in the group practice reviewed guidelines for both influenza and
pneumococcal vaccines.
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Figure 1. The Communication Human Information Processing model [22,23].
Phase 2: Interactive Voice Recognition and Portal
Randomized Outreach Intervention
Clinical Setting
This study will be conducted at RMG, a large multispecialty
group that employs 217 outpatient physicians at more than 13
clinical locations throughout Central Massachusetts. RMG
providers care for approximately 140,000 adults aged 18 years
and older. Approximately 113,000 of these adults receive their
primary care through RMG via either the internal
medicine/geriatric or family medicine departments.
Approximately 89.5% of RMG patients are white, 4.3% are
African American, and 4.6% Asian.
Electronic Health Record
All RMG providers and staff use an EHR developed by Epic
Systems Corporation. Consistent with evidence showing that
CDS can improve rates of indicated vaccines [25-27], the RMG
EHR is configured to flag a patient’s record when they are due
or overdue for an immunization based on the patient’s age,
immunization history, medical, surgical, and social history.
When patients call or are seen at RMG, physicians and staff
accessing the patient’s record are alerted to immunizations that
are due or overdue. Using a Microsoft SQL Server database,
which is updated nightly with all of the clinical data from the
EHR, it is possible to identify patients aged 18 years and older
who are eligible and in need of immunizations.
Electronic Patient Portal
All RMG patients are given the option to sign up for MyChart,
an electronic patient portal within Epic that is free of cost to
patients and provides them with personalized and secure online
access to portions of their medical record. Over 30% of RMG
patients use MyChart. Patients can view their immunization
history as well as alerts for immunizations that are due or
overdue. They can securely send messages to and receive
messages from RMG providers. The Epic MyChart system has
the capacity to survey selected populations of patients.
Current Use of Interactive Voice Recognition Technology
RMG has an ongoing relationship with a company that uses
IVR calls to alert patients about upcoming appointments and
allows patients to respond to a limited number of scripted
questions. Standard operating procedures and methods for
transferring patient data existed prior to the intervention and
helped guide our protocols.
Participants
Eligibility Criteria
Patients are eligible for the study if they (1) have had an RMG
primary care provider during the 1 year prior to randomization;
(2) are aged 18 years or older on the date of randomization; (3)
have had a recent office visit or telephone encounter with an
internal medicine practitioner or family practitioner. The
requirement for a recent office visit or telephone encounter was
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intended to minimize inclusion of patients who had moved to
another practice but whose names were retained in RMG
records. Our definition of “recent” depended on patient’s age.
We defined “recent office visit” based on the age group of the
patients; because older RMG patients (aged ≥ 65 years) visit
their providers more frequently, we required an office visit or
phone encounter within the 18 months prior to randomization
for this population. For adults aged 18-64, we required an office
visit or phone encounter within the 3 years prior to the
intervention. To ensure capture of patients transitioning from
pediatric to adult care, the visit or phone call could also be with
a pediatrician.
Exclusion Criteria
Patients will be excluded if there is EHR documentation of an
allergy to influenza vaccine, or if they were one of 20 patients
who participated in preliminary qualitative interviews conducted
to inform development of outreach materials. Exclusion criteria
also included the presence of any of the following on the date
of randomization: (1) EHR documentation of influenza
vaccination completion in the 2014-15 influenza season (or
documented influenza vaccination after the end of the 2013-14
influenza season but before the start of the 2014-15 season); (2)
name listed on the do-not-call list or no listed phone number.
A patient is eligible for inclusion in the electronic patient portal
(referred to as “portal” herein) portion of the randomized
controlled trial if he or she is an active user, which is defined
as having an activated portal with a login at least once in the
year preceding randomization.
Randomization Approach
Using computer-generated random number assignments, we
will randomly select from the eligible population 20,000 portal
users and 10,000 nonportal users (total of 30,000 patients).
Using a factorial design (Figure 2), we will then use a
computerized randomization method to assign 5000 patients to
each of the 4 arms (portal users) and, separately, to each of the
2 arms (nonportal users). Thus, we will have a total of 6 arms,
each with 5000 patients.
Recruitment and Informed Consent
The study was reviewed and approved in 2014 by the RMG
Institutional Review Board (IRB) and subsequently (in 2015)
oversight was transferred to the University of Massachusetts
IRB. A waiver for informed consent for patient outreach was
approved by the IRB.
Intervention
We designed the IVR calls and portal messages to include
similar content (Textbox 1)
Figure 2. Outreach design.
Textbox 1. IVR call and portal message content
IVR calls and portal messages included...
• Personalized greeting
• Message seeking to establish influenza vaccines as social norm (“people your age get vaccinated against the flu...”) and informing patients what
age group vaccines are recommended for
• Information intended to optimize access to vaccines (dates/locations for upcoming Reliant Medical Group (RMG) influenza clinic and list of
additional ways to schedule a vaccine appointment)
• Information on accessing the CDC website for vaccine information
IVR calls and portal messages sought to elicit patient responses
• Patients were asked whether they had received influenza vaccines outside of RMG and were offered an opportunity to report date and location
of influenza vaccinations received at external sites
• For patients who responded that they had not received any influenza shot for the 2014-15 season, several questions addressing vaccine barriers
were presented
• Targeted educational information dispelling myths and misconceptions about the influenza vaccine based on patient responses to barrier questions
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Electronic Patient Portal Intervention
We designed an outgoing secure portal message to be sent via
MyChart to patients randomized to the portal message arms
(see Multimedia Appendix 1). Portal message content will
appear in letter format with the signature line reflecting the
name of the patient’s primary care provider. Portal messages
will be delivered through standard channels used for portal-based
correspondence between RMG health care providers and patients
(ie, generic message that contains no personal health information
nor any reference to vaccines is delivered to patient’s email
account. Message prompts patients to log into secure portal
account via hyperlink). Once logged into portal accounts,
patients must click on a message labeled “Brief Flu
Questionnaire” to view the outreach message.
Characteristics unique to the portal message compared with
IVR messages include the ability to offer direct online
scheduling of appointments for influenza vaccines. Information
about accessing CDC vaccine website(s) appears within the
body of the portal message as a hyperlink (and is conveyed
verbally in the IVR script). Opportunities to report external
influenza vaccinations, vaccine barrier questions, targeted
information dispelling misconceptions, and branching logic
matched the IVR call content.
Portal Message Delivery
To reach unvaccinated patients, we will intervene 2 months into
the influenza season, a practice supported by prior research [28].
Messages will be sent out to 500-1500 patients daily over 9-10
days, beginning 1-week postrandomization.
Interactive Voice Recognition Call Intervention
We designed a script to be delivered via IVR call to patients
randomized to the IVR arms. Combining voice recognition with
branching logic, calls will elicit patient self-report of influenza
vaccinations completed outside of RMG. For patients reporting
no influenza vaccine completion, IVR calls will deliver a series
of questions on vaccine barriers, providing brief information
intended to address the barriers which the patient identifies.
IVR calls will appear on telephone caller ID as “RELIANT
MED.” This is consistent with current identification of IVR
calls used for appointment reminders and is a detail that we
consider critical to the success of call answering.
Interactive Voice Recognition Call Delivery
Intervention IVR calls will be placed using standard procedures
suggested by the IVR design team, which include identification
of optimal times to call based on the patient’s age and
suggestions for keeping patients engaged to achieve study goals.
IVR calls will begin by confirming the patient’s identity. If
voicemail is encountered or if the person reached identifies
himself or herself as someone other than the patient, the IVR
system will leave a message asking patients to call back and
providing an inbound call line number. An inbound call line
will be maintained throughout the duration of outgoing calls
and for 2 weeks after the final outgoing call is placed, and
patients calling this number from the phone number of record
will hear the IVR call script in its entirety, beginning with
questions confirming the identity of the caller.
Data Upload Into Epic Electronic Health Record
Patient reports of prior immunization dates and location will be
loaded through Epic’s Inbound Immunization interface and will
be incorporated into the patient’s medical record. Data derived
from portal questionnaires, including information on patient
barriers, will be stored and available to the project team for
analysis.
Patient-reported immunization type, mapped to “Codes for
Vaccine Administered” (CVX code), date of vaccination,
location of vaccination, and reasons for not being immunized
will be sent to the study team by the company providing IVR
calls. The patient’s immunization history will be updated via
Epic’s Inbound Immunization interface, and transcriptions of
all IVR responses will be stored for analysis by the project team.
Measures
We will draw on data from EHR records, brought into the EHR
via several pathways. Information on influenza vaccines will
be gathered by capturing data entered into the EHR via two
routes: (1) direct documentation by RMG staff of influenza
vaccines administered at RMG or reported in-person by the
patient and entered manually into Epic EHR by staff or provider;
(2) patient self-report of vaccines administered outside of RMG
(self-report received via MyChart questionnaire or IVR).
Primary Outcome
Influenza Vaccine Outcomes
Our primary outcome will be percentage of eligible patients
with influenza vaccines directly administered and documented
in an RMG facility as of the end of the 2014-15 influenza
season. Because the control groups will not be given the
opportunity to self-report, immunizations captured solely
through the MyChart questionnaire or the IVR will be excluded
from the primary analysis. Our exclusion of self-reported
vaccines from our outcome analysis avoids introducing bias
through differential capture (intervention vs control) of
self-reported outcomes.
Secondary Outcome
Influenza Vaccine Outcomes
We will perform a descriptive analysis, calculating the
percentage of patients for whom self-report through our
intervention was the sole method for documentation of influenza
vaccination completion. We will assess this at the end of the
2014-15 influenza season. This analysis is intended to provide
preliminary insights into the percentage of patients who are
vaccinated outside of the RMG clinics and who choose to
self-report these vaccines.
Process Measures
We will examine patients who receive portal messages and
calculate (1) percentage of recipients who open messages and
(2) percentage of recipients who complete questionnaires. We
will examine patients who receive IVR calls and calculate (1)
percentage of recipients who answer the call and (2) percentage
of recipients who complete the calls by responding to questions.
JMIR Res Protoc 2016 | vol. 5 | iss. 2 | e56 | p.6http://www.researchprotocols.org/2016/2/e56/
(page number not for citation purposes)
Cutrona et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
Proposed Analyses
To determine the impact of our interventions on RMG
vaccination rates for the 2014-15 influenza season, we will
perform unadjusted and adjusted analyses of randomized patients
(30,000 patients). Because of differential rates of vaccination
at baseline between portal users and nonusers, analyses in these
groups will be conducted separately. Intention-to-treat
unadjusted chi-square analyses will include the analyses
presented in Table 1.
We will examine the adequacy of randomization in the overall
group and separately among e-portal users and non e-portal
users by assessing whether there was differential representation
in the intervention versus control groups by 5 patient
characteristics readily available in the EHR. These will include
(1) age group; (2) race/ethnicity; (3) sex; (4) influenza
vaccination in previous year; and (5) completion of an office
visit in the previous year; if differences are found we will carry
out adjusted analyses using logistic regression to control for
significant differences, modeling odds of receiving influenza
vaccine.
Multivariate logistic regression analyses will also be performed.
As in our unadjusted analyses, due to differential rates of
vaccination at baseline between portal users and nonusers,
adjusted analyses in these groups will be conducted separately.
We will create dummy variables for assignment to the portal
message arm (among portal users) and for assignment to the
IVR call arm (among both portal users and, separately, among
nonportal users). Including these dummy variables and adjusting
for demographic and practice-level covariates, we will model
odds of receiving an influenza vaccine in the 2014-15 influenza
season. We will also examine the heterogeneity of treatment
effects within each subgroup using logistic analysis.
Power and Sample Size
With our proposed sample size and using a factorial design,
power calculations using baseline vaccination rate estimates
indicated that 4286 participants per arm would give 80% power
to detect a 3% improvement in influenza vaccination rates
between groups (α=.05; 2-sided). Based on previous studies
[29,30], we expect a 10-20% improvement in vaccination rates
for either intervention compared with control.
Table 1. Analyses by arm.
ComparisonStudy question
Compare percentage of vaccine completion among those randomized to
receipt of portal messages versus those randomized to neither portal mes-
sages nor IVR calls (usual care).
(Arm 2 vs 4)
Among portal users, did portal message receipt alone increase the likeli-
hood of influenza vaccine completion compared with control?
Compare percentage of vaccine completion among those randomized to
receipt of both portal messages and IVR calls versus those randomized to
only portal messages.
(Arm 1 vs 2)
Among portal users, did portal message receipt plus IVR call increase the
likelihood of influenza vaccine completion compared with portal message
alone?
Compare percentage of vaccine completion among those randomized to
receipt of IVR calls versus those randomized to neither portal messages
nor IVR calls (usual care).
(Arm 3 vs 4)
Among portal users, did IVR call alone increase the likelihood of influenza
vaccine completion compared with control?
Compare percentage of vaccine completion among those randomized to
receipt of IVR calls versus those randomized to neither portal messages
nor IVR calls (usual care).
(Arm 5 vs 6)
Among those who do not use portals, did IVR call alone increase the
likelihood of influenza vaccine completion compared with control?
Results
Intention-to-treat unadjusted chi-square analyses will be
performed to assess the impact of portal messages, either alone
or in combination with the IVR call, on influenza vaccination
rates.
Discussion
This study will test the effectiveness of a patient-directed CDS
intervention, aimed at improving rates of influenza vaccination
within a primary care adult population. The approach described
has important implications for future patient-directed CDS
initiatives seeking to use tethered patient portals. As a low-cost
and rapid means of communicating with patients who have
activated their electronic accounts, patient portals are a
promising channel through which CDS may be delivered.
Targeting patients through portals aligns well with the “CDS
Five Rights,” which stipulate that effective CDS delivers the
right information to the right people, via the right channels, in
the right intervention formats and at the right points of workflow
[31]. Our approach studies the possibility that the patient is the
person best positioned to receive and act on information related
to influenza vaccination.
Influenza vaccination has several characteristics that made it
ideally suited for this study design. Influenza vaccinations are
a single-dose annual vaccine, for which standing orders were
already in place in our medical group. They are recommended
almost universally across age groups, and therefore, we did not
require that physicians review the list of patients to whom
promotional messages were directed prior to sending, thereby
reducing physician burden. There is widespread familiarity with
influenza vaccination among the lay public, and numerous
community sites and workplaces offer these vaccinations, thus
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they are commonly administered outside of the medical group.
Seeking to collect data on vaccinations given in the community
was therefore a reasonable component of our outreach. This
factor might be less appropriate for other preventive health
behaviors. Guidelines calling for annual vaccination create a
short recall period (2-3 months in our study design) for
individuals reporting vaccination in a given season. The short
recall period and widespread familiarity was our rationale for
accepting patient self-report. With inputs from the physicians
on our research team, we further reasoned that providers would
be willing to update the EHR based on patient self-report of
influenza completion during an in-person visit (without
accompanying printed documentation) and that our collection
of self-reported data via outreach was an acceptable alternative
to in-person patient report. Our outreach may have the additional
benefit of identifying patients with influenza vaccine allergy
that has not previously been documented.
This protocol has some limitations. Although we collected
self-report of influenza vaccinations completed in the
community, our primary analysis focuses on RMG-documented
vaccines, thus avoiding the bias that would be introduced
through differential capture (intervention versus control) of
self-reported data.
For our secondary outcome measurement, we will report
percentage of patients self-reporting influenza vaccines
completed in the community. Although self-report introduces
the possibility for inaccuracies, self-reported vaccination status
is a measure commonly used to assess vaccination status and
is the standard used by the Behavioral Risk Surveillance System
and the National Health Interview Survey [32-34]. Previous
validation efforts for self-reported influenza vaccines
documented high sensitivity (0.98 to 1.0) and moderate
specificity (0.71-0.79) [32]. In addition to reviewing commonly
accepted measures and published validation reports, we also
considered the levels of ascertainment consistent with routine
clinical care. Many clinicians accept a patient’s verbal self-report
of completed influenza vaccination and update the EHR
accordingly (without requiring paper documentation). For all
of these reasons, we chose to allow patient self-reported
influenza vaccinations to be entered into the EHR.
An additional limitation of our study stems from the timing of
outreach. After eligibility determination but prior to
disseminating the outreach, we will have a 1-week gap built in
for quality checks and data transfers to the company handling
IVR calls. It is possible that during this 1-week gap, patients
randomized to receipt of the intervention will obtain their
influenza vaccines. Patients with vaccinations completed during
this period should be evenly distributed across all arms,
minimizing any associated bias. Once the intervention starts,
IVR calls and patient portal messages will be disseminated in
batches. While this is a standard protocol for delivering IVR
appointment reminders and prevents outgoing portal messages
from being labeled as spam by email servers, it also introduces
the possibility that additional patients may get vaccinated prior
to receiving the intervention. Again, patients vaccinated prior
to receipt of messages should be evenly distributed across all
arms.
While our single-site study is limited insofar as it cannot be
considered representative on a national scale, a future study
could address this by sampling from our population in proportion
to national demographics. In addition, we have designed our
intervention to be easily tested across diverse settings. This
intervention will be implemented using Epic, one of the top
EHR vendors in the country [35]. If successful, this study’s
intervention may be adapted by other large health care
organizations using Epic and tested as a means of increasing
vaccination rates among diverse populations.
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